AmyPore is the maker of AmyP53, a drug that seeks to counter Alzheimer’s and Parkinson’s diseases. They generate their drugs though innovative strategy of AI for molecular neuroscience. Their drug is among the first representatives of a new therapeutic class that prevents a major mechanism common to the two diseases.
Biotechnology, Health Care, Pharmaceutical
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as AmyPore? We’re happy to assist you with our Startup Sourcing service.